Submitted by Anonymous (not verified) on 20 October 2023 - 11:06
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Epilepsies, Myoclonic, Date of authorisation: 18/12/2020, Revision: 7, Status: Authorised
Source: